Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Ventriculography |
Dose: Injection – 40 mL (range 30-60 mL) Frequency: as needed Note: Not to exceed 250 mL |
|
Indication: Selective Coronary Arteriography |
Dose: Injection – 5 mL (range 3-14 mL) Note: Per injection |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Ventriculography Age: Pediatric |
Dose: Iohexol 350 – 1.25 mL/kg Note: range 1-1.5 mL/kg; not to exceed 5 mL/kg or 250 mL, when multiple injections given |
|
Indication: Ventriculography Age: Pediatric |
Dose: Iohexol 300 – 1.75 mL/kg Note: range 1.5-2 mL/kg; not to exceed 6 mL/kg or 291 mL, when multiple injections given |
Administration
- Hospital use only
- Given by healthcare provider
Side Effect
- Flushing or a sensation of heat
- pain
- extravasation
- thrombophlebitis at the Injection site
- nausea
- vomiting
- headache
- and dizziness
- urticaria
- pruritus
- pallor
- sweating
- metallic taste
- weakness
- coughing
- rhinitis
- sneezing
- lachrymation
- visual disturbances
- hypotension
- tachycardia
- bradycardia
- transient ECG abnormalities
- haemodynamic disturbances
- dyspnoea
- bronchospasm
- angioedema
- severe urticaria
- convulsions
- paraesthesia
- paralysis
- acute renal failure
- thromboembolism
- disseminated intravascular coagulation
- thrombocytopenia
- hyperthyroidism
- thyroid storm thyrotoxicosis
- Profound hypotension
- pulmonary oedema
- respiratory arrest
- ventricular fibrillation
- circulatory failure
- cardiac arrest
- coma
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
No interactions listed
|
-
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Significant Local Or Systemic Infection
|
Can worsen infection spread
|
|
Repeat Myelography After Technical Failure
|
Risk of overdose
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store at room temperature below 30° C and protect from light and secondary X-rays. The product in glass vials and bottles may be stored at 37° C for up to 3 months prior to use.Do not freeze.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.